Clinical Trial Update: GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy

View source ↗

Summary

A completed clinical trial evaluating GANfort (bimatoprost/timolol) in patients with open-angle glaucoma or ocular hypertension who were insufficiently responsi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Ganfort (bimatoprost; timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2012-09-24